NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,548,978 | -72.7% | 591,268 | -29.8% | 0.00% | -71.4% |
| Q2 2023 | $34,953,168 | +56.9% | 842,245 | +127.3% | 0.01% | +75.0% |
| Q1 2023 | $22,281,269 | -22.5% | 370,490 | -5.5% | 0.00% | -42.9% |
| Q4 2022 | $28,755,401 | +31.3% | 392,030 | +36.0% | 0.01% | +16.7% |
| Q3 2022 | $21,901,000 | -25.0% | 288,257 | -31.4% | 0.01% | -14.3% |
| Q2 2022 | $29,198,000 | -17.1% | 420,123 | -1.1% | 0.01% | +16.7% |
| Q1 2022 | $35,201,000 | -51.3% | 424,875 | -55.9% | 0.01% | +200.0% |
| Q4 2021 | $72,304,000 | -15.9% | 963,018 | +30.1% | 0.00% | -83.3% |
| Q3 2021 | $85,996,000 | -0.5% | 740,264 | +90.0% | 0.01% | 0.0% |
| Q2 2021 | $86,433,000 | +3.1% | 389,651 | -38.6% | 0.01% | -7.7% |
| Q1 2021 | $83,867,000 | -77.6% | 634,493 | -70.6% | 0.01% | -56.7% |
| Q4 2020 | $374,040,000 | +345.9% | 2,161,580 | +186.8% | 0.03% | +76.5% |
| Q3 2020 | $83,889,000 | +28.8% | 753,653 | -31.4% | 0.02% | +13.3% |
| Q2 2020 | $65,110,000 | +4.8% | 1,097,975 | +19.0% | 0.02% | -21.1% |
| Q1 2020 | $62,153,000 | +33.6% | 922,975 | +67.2% | 0.02% | +46.2% |
| Q4 2019 | $46,510,000 | +4.2% | 551,904 | -7.6% | 0.01% | -13.3% |
| Q3 2019 | $44,643,000 | -45.5% | 596,982 | -53.9% | 0.02% | +36.4% |
| Q2 2019 | $81,930,000 | +333.9% | 1,295,739 | +230.5% | 0.01% | +37.5% |
| Q1 2019 | $18,882,000 | +14.4% | 392,000 | -20.5% | 0.01% | +14.3% |
| Q4 2018 | $16,506,000 | -54.3% | 493,000 | -28.5% | 0.01% | -41.7% |
| Q3 2018 | $36,135,000 | +90.4% | 689,600 | +13.7% | 0.01% | +71.4% |
| Q2 2018 | $18,980,000 | +2.0% | 606,400 | -28.9% | 0.01% | 0.0% |
| Q1 2018 | $18,600,000 | -2.9% | 853,200 | -10.0% | 0.01% | 0.0% |
| Q4 2017 | $19,146,000 | -5.4% | 947,800 | -7.1% | 0.01% | -12.5% |
| Q3 2017 | $20,243,000 | +96.3% | 1,019,800 | +71.1% | 0.01% | +60.0% |
| Q2 2017 | $10,313,000 | +113.9% | 596,100 | +0.2% | 0.01% | +150.0% |
| Q1 2017 | $4,821,000 | +17.9% | 595,100 | +14.3% | 0.00% | 0.0% |
| Q4 2016 | $4,088,000 | +210.2% | 520,704 | +237.2% | 0.00% | – |
| Q3 2016 | $1,318,000 | -29.9% | 154,400 | -4.2% | 0.00% | -100.0% |
| Q2 2016 | $1,881,000 | -14.0% | 161,200 | +6.8% | 0.00% | 0.0% |
| Q1 2016 | $2,186,000 | -34.5% | 150,969 | +1.1% | 0.00% | -50.0% |
| Q4 2015 | $3,338,000 | – | 149,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |